Business
Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
Industry News
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Cryptocurrency
Crypto
Cryptocurrency
Blockchain
Markets
Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
Politics
US
World
White House
Elections
General News
Forex
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment
Top Stories
Music news
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium Services
Premium
Intelligent Investor
Biotech Investor
NEW
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Business
Corp. News
Latest Headlines
Biotech
Investors
Stock Alerts
IPOs
M&A
Top Stories
Breaking News
Earnings
Canadian
UK
Wallstreet Events
Industry News
Technology
Software
Banking
Automotive
Energy
More
Corp. Calendars
Dividends
Stock Splits
Buybacks
Conference Calls
Earnings Calendar
Earnings Calendar
Pos Pre-announcements
Profit Warnings
Positive Surprise
Negative Surprise
Latest Earnings
FDA Calendars
Drug Approvals
Clinical Trial Calendar
Ratings Changes
Upgrades
Downgrades
Cov Initiations
Cov. Reiterated
Economy
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard
Crypto
Cryptocurrency
Blockchain
Markets
Market News
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies
Politics
US
World
White House
Elections
General News
Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard
Health
Health News
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health
Slide Shows
Entertainment
Entertainment News
Top Stories
Music News
Pop
Rock
Classic Rock
Rap/Hip-Hop
Country
Alternative
Oldies
All Genre
Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services
Premium
Intelligent Investor
Biotech Investor
Login
More
Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us
Abbvie (ABBV)
AbbVie Submits FDA Application For RINVOQ In Severe Alopecia Areata Based On Phase 3 Data
4/28/2026 8:13:26 AM
AbbVie Says Rinvoq Tops Humira In Rheumatoid Arthritis Study
4/28/2026 7:35:05 AM
AbbVie : RINVOQ Outperforms HUMIRA In Head-to-Head Rheumatoid Arthritis Study
4/28/2026 7:04:05 AM
AbbVie Seeks FDA Nod For SKYRIZI Subcutaneous Induction In Crohn's Disease
4/27/2026 8:32:06 AM
AbbVie Submits Regulatory Application To FDA For SKYRIZI SC Induction For Adults With Active Crohn's Disease
4/27/2026 8:09:25 AM
Weekly Buzz: SNY, REGN Get FDA Nod; It's A No For ABBV, GRCE; LLY Acquires Kelonia
4/24/2026 10:34:13 AM
AbbVie: FDA Issues CRL For TrenibotulinumtoxinE Related To Manufacturing Processes
4/24/2026 1:20:25 AM
AbbVie Receives FDA Complete Response Letter For TrenibotE Biologics License Application
4/23/2026 9:51:49 PM
AbbVie Announces Founding Sponsorship Of BioLabs University Of Toronto
4/21/2026 12:19:13 AM
AbbVie Expands Partnership With BioLabs As Founding Sponsor Of New University Of Toronto Hub
4/20/2026 10:08:10 PM
Nxera Pharma To Receive $10 Mln Milestone Payment From AbbVie Under Neurology Collaboration
4/20/2026 2:53:44 AM
Nxera Pharma Reaches Third R&D Milestone In AbbVie Collaboration, Secures $10 Mln Payment
4/20/2026 2:35:40 AM
Haisco Reaches Deal With AbbVie To Develop Novel Medicines For Pain
4/13/2026 2:37:03 AM
AbbVie's Phase 2 Trial Shows 62.7% Response With Mirvetuximab In Platinum-Sensitive Ovarian Cancer
4/12/2026 10:45:15 AM
Allergan Aesthetics Highlights TrenibotE Safety And Medical Weight Loss Insights At AAD 2026
3/30/2026 8:05:06 AM
AbbVie To Showcase New Clinical And Real-World Evidence In Immune-Mediated Skin Diseases At 2026 AAD
3/27/2026 10:03:06 AM
Allergan Aesthetics To Unveil Next Evolution Of AA Signature At AMWC 2026
3/19/2026 3:04:45 AM
AbbVie Reports Positive Topline Results In Phase 1 Study For ABBV-295 In Weight Management
3/9/2026 8:24:42 AM
AbbVie Reports Positive Phase 1 Results For ABBV-295, Long-Acting Amylin Analog In Weight Management
3/9/2026 8:05:22 AM
AbbVie Reports Positive Phase 3 Results For Risankizumab In Crohn's Disease
3/2/2026 9:20:01 AM
1
2
Next
»